This week on IPWatchdog Unleashed we have a conversation about one of the hottest topics not just in the intellectual property world, but one of the topics that everyone both inside and outside of government is discussing. The cost of prescription pharmaceuticals is higher in the United States than anywhere else in the world, and many in the United States—including President Trump—are fed up with this imbalance. 

So, we will set the record straight and explain what is really causing Americans to pay high drug prices. To accomplish this my conversation is with Corey Salsberg, who is Vice President and Global Head of IP Affairs for Novartis, which is one of the leading and most innovative biopharmaceutical companies in the world. We discuss the issues that matter for the pharmaceutical industry, including what and who is really responsible for higher drug prices in America. We discuss President Trump’s attempts to force most favored nation (MFN) pricing that would demand the U.S. pay no more than what other countries pay for drugs. And we also take a moment to discuss the recent tragic deaths of Malcolm Jamal Warner, Ozzy Osbourne, and Hulk Hogan, and the future of artificial intelligence (AI).

Visit us online at IPWatchdog.com.

You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.